Minimal residual disease detection in myeloma: no more molecular remissions?

Andy C Rawstron1

  • 1HMDS, Algernon Firth Building, Leeds Teaching Hospital, Leeds, UK. andy.rawstron@hmds.org.uk

Haematologica
|October 13, 2005
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos